Search

everythinglearnresearchcommunity

for

Search:↓

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Fractional and excimer lasers effectively treat various types of alopecia and promote hair growth.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Ayurvedic treatment successfully regrew hair in a 7-year-old girl with alopecia areata.

Early-stage Alopecia Areata was effectively treated in less than six months.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

The summit aimed to speed up finding treatments for alopecia areata.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Stem cell therapy may help treat tough hair loss cases.

Topical minoxidil is a safe and effective treatment for hair loss caused by androgenetic alopecia.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Hair loss requires customized treatments based on its various causes and types.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

A patient lost all their hair while on rheumatoid arthritis medication.